George Melko, Vice President, Regulatory Affairs at Tyra Biosciences

George Melko

Vice President, Regulatory Affairs at Tyra Biosciences | Mickleton, New Jersey, United States

Profile last verified August 2026
Pharmaceuticals Verified Profile Mickleton, New Jersey, United States University of the Sciences in Philadelphia
Verified

Personal Email

***@comcast.net

Personal • High Confidence

Phone Number

856*****

United States • Mobile

Free account · No credit card · 5 profiles/month

George Melko Socials
George Melko Work Experience

Vice President, Regulatory Affairs at Tyra Biosciences in July 2023 - Present

SENIOR VICE PRESIDENT, REGULATORY AFFAIRS at Tessa Therapeutics Ltd in July 2022 - October 2023

VICE PRESIDENT, REGULATORY AFFAIRS & QUALITY ASSURANCE at Aptose Biosciences, Inc. in January 2021 - September 2022

See more See less

VICE PRESIDENT, REGULATORY AFFAIRS at Tmunity Therapeutics Incorporated in January 2020 - January 2021

VICE PRESIDENT, REGULATORY AFFAIRS at Tessa Therapeutics Ltd in January 2019 - January 2020

EXECUTIVE DIRECTOR, REGULATORY AFFAIRS (2017-2019) at Incyte in January 2007 - January 2019

ASSOCIATE DIRECTOR, REGULATORY AFFAIRS at AstraZeneca in January 2003 - January 2007

PROJECT MANAGER, REGULATORY AFFAIRS at AstraZeneca in January 2000 - January 2003

MANAGER, REGULATORY AFFAIRS LABELING GROUP at AstraZeneca in January 1999 - January 2000

George Melko Education

University of the Sciences in Philadelphia, PharmD, January 1993

Rutgers, The State University of New Jersey-New Brunswick, Bachelors, January 1982

George Melko Skills
Global Regulatory Development Planning EMA Submissions FDA Submissions Pharmaceutical Industry Regulatory Submissions Regulatory Affairs Clinical Development Clinical Trials Drug Development GCP
See more See less
Regulatory Requirements Oncology FDA Biopharmaceuticals Pharmacovigilance Therapeutic Areas Strategy Development Competitive Analysis Budget Management Due Diligence Program Management Project Management Regulatory Compliance Regulatory Strategy Risk Assessment Leadership Development Negotiations Relationship Management Team Building Training Development IND NDA eCTD Toxicology Document Preparation Regulatory Operations Hematology & Onology Academic Institution Partnerships Agency Communications Briefing Package Design Business Growth Initiatives Core Data Sheet Preparation Electronic NDAs Global Health Organizations Innovative Compounds NDA Submissions Package Insert Design Policy & Procedure Design Product Collaboration Protocol Creation
About George Melko’s Current Company
Tyra Biosciences

Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNÅP, enables the rapid and precise refinement of structural drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. TYRA is based in Carlsbad, CA.

Discover more about Tyra Biosciences
George Melko’s Colleagues
Jignesh Patel

Jignesh Patel

Boston, Massachusetts, United States

Associate Director, Drug Product Development & Technical Ops at MorphoSys

R&D/ Mfg Scientist III at Thermo Fisher Scientific
(September 2026 – September 2026)

Fernando Miguel

Fernando Miguel

San Diego Metropolitan Area

Principal Scientist at Tyra Biosciences

Member & Volunteer at Españoles Científicos en USA (ECUSA)
(September 2020 – Present)

Curt Dvorak

Curt Dvorak

Carlsbad, California, United States

Senior Director of Medicinal Chemistry at Tyra Biosciences

Senior Director of Medicinal Chemistry at Tyra Biosciences
(March 2022 – Present)

Emily Pettitt

Emily Pettitt

United States

Senior Research Associate at Tyra Biosciences

Senior Research Associate at Tyra Biosciences
(March 2024 – Present)

DG

Dinesh Ganapathy

Covington, Kentucky, United States

Medical Affairs Leader | Strategic Medical Education & Clinical Research Expert | Driving Innovation in Pharmaceutical Industry

Unaffiliated IRB Board Member at Univo IRB
(April 2022 – Present)

AF

Ali Fawaz

New York City Metropolitan Area

General Counsel and Corporate Secretary

General Counsel and Corporate Secretary at Tyra Biosciences
(May 2022 – Present)

Search similar profiles
Frequently asked questions about George Melko

What is George Melko email address?

Email George Melko at [email protected] and [email protected]. This email is the most updated George Melko's email found in 2026.

What is George Melko phone number?

George Melko phone number is 8562238760.

How to contact George Melko?

To contact George Melko send an email to [email protected] or [email protected]. If you want to call George Melko try calling on 8562238760.

What company does George Melko work for?

George Melko works for Tyra Biosciences.

What is George Melko's role at Tyra Biosciences?

George Melko is Vice President, Regulatory Affairs

What industry does George Melko work in?

George Melko works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free